Corteneinc
1 known investors
Cortene develops a peptide-based treatment targeting brain-centric acquired chronic diseases such as Parkinson's, Alzheimer's, and autoimmune conditions. The company focuses on addressing root causes in conditions affecting millions of patients globally.
BiotechHealthtechMedical Devices